Journal of Pharmacy Practice and Pharmaceutical Sciences

ISSN: 2652-2536

Research Article

The Effects of Bisphenol A and Di-Isononyl Phthalate on Conformational Stability and Activity of Lysozyme

Sarah Grothen1 and Somnath Singh2*

1School of Pharmacy and Health Professions, CreightonUniversity, Omaha, USA

2Pharmacy Sciences, Creighton University, Omaha, USA

Received: 01 September 2018

Accepted: 28 September 2018

Version of Record Online: 24 October 2018


Grothen S, Singh S (2018) The Effects of Bisphenol A and Di-Isononyl Phthalate on Conformational Stability and Activity of Lysozyme. J Pharm Pract Pharm Sci 2018(1): 01-08.

Correspondence should be addressed to

Somnath Singh, USA


DOI: 10.33513/PPPS/1801-02


Copyright © 2018 Somnath Singh et al.This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and work is properly cited.


The purpose of this study was to investigate the effect of Bisphenol A (BPA) and Di-Isononyl Phthalate (DINP) on conformational stability and biological activity of a model protein lysozyme. Lysozyme was incubated to various concentrations (2-100 μM) of bisphenol A and phthalate for 6 weeks. The conformational stability of lysozyme was figured out by using Differential Scanning Calorimeter (DSC) and Fourier Transform Infrared (FTIR) spectrophotometer. Biological activity of the samples was determined by an enzyme activity assay using Micrococcus lysodeikticus (M. luteus) as a specific substrate to lysozyme. A rate of change of 0.001 in absorbance at 450 nm (A450 nm) was used to define 1 unit of biologically active lysozyme. The DSC data showed significant (p<0.05) decrease in Tm and H values for lysozyme samples treated with BPA or DINP with increase in exposure time. The H value of BPA treated 7 day’s sample was negative which may indicate complete reversal of conformational integrity. In 7 days old DINP treated sample, no measurable peak was observed which may be due to complete loss of conformational structure. DSC data were further corroborated by FTIR and biological activity data. FTIR spectra of all the treated lysozyme samples showed the splitting of β sheet secondary structure which was completely lost in 7 days DINP treated samples which also showed the minimal biological activity. BPA and DINP (constituents of plastic bottles) may disrupt the conformational stability of protein which is expected to be more severe in human where they can remain longer than the 7 day’s exposure period used in this study.

Keywords: Bisphenol A; Conformational Stability; Di-Isononyl Phthalate; Lysozyme


Plastics are incredible materials; they are easy to manufacture, impervious to water, inexpensive, lightweight, strong, durable, and corrosion-resistant with high thermal insulation properties. A range of chemicals are added to plastics during manufacture, to enhance the performance of plastics. These additives can be referred to as plasticizers and include flame retardants, stabilizers, softeners, coupling agents, pigments, extenders, and lubricants that give each type of plastic its unique properties [1]. Huge concern has been raised over these potentially harmful chemical additives including phthalates, Bisphenol A (BPA) and Polybrominated Diphenyl Ethers (PBDE) which improve the properties of plastics yet leak into the environment, food and beverages [2,3]. These chemicals could be transferred to humans either indirectly through widespread plastic piping used to deliver potable water and food packaged in plastics containing these additives, or, directly from toys mouthed by toddlers [1,4,5]. These compounds may act as Endocrine-Disrupting Compounds (EDC’s), and can result in adverse developmental and reproductive effects[6-8]. In men, effects of the environmental or occupational exposures of EDC may be manifested as declined reproductive capacity, reduction in semenquality, infertility or possibly increased risk of testicular or prostate cancer [2]. Bisphenol-A (BPA) is a key component used to make epoxy resins and polycarbonate plastic which is used to make consumer goods. Polycarbonate plastic is clear, strong, lightweight, and heat resistant which makes it ideal for use in water bottles, food containers and medical equipment’s. Likewise, epoxy resin coatings are durable, adhere well to metal, and chemical resistant thus they are ideal for use as a protective coating on food cans (

BPA is found to leach out in discerning amounts as evident from the detectable amounts found in food cans, microwave containers, polycarbonate bottles, and in human saliva after treatment with dental sealants [9]. Recent studies on human exposure to BPA, have shown a two-third increase in the urinary concentration of the BPA molecule following the use of polycarbonate drinking bottles for 1 week [10]. Effects of BPA are a function ofthe species, strain, dose, and time of exposure. Adult animals have shown reversible effects in response to BPA exposure. In contrast to this, irreversible organizational effects were produced in Sprague-Dawley rats after neonatal and perinatal exposure [11]. BPA at high and low doses causes long-term adverse reproductive and carcinogenic effects if exposure occurs during critical periods of differentiation, causing precocious hypothalamic-pituitary maturation and precocious puberty [12,13]. Prenatal exposure to BPA is associated with an increase in the risk for breast cancer [14]. Rodent studies have shown that prenatal and neonatal exposure to BPA results in early onset of sexual maturation, reproductive tract lesions, and altered development of the mammary gland [15]. Recent studies have shown that hormonal perturbations during fetal or neonatal development may predispose individuals to reproductive problems including infertility/sub fertility; and increased tumors such as uterine fibroids and breast cancer [12].

Phthalates are primarily used as plasticizers in the manufacture of flexible vinyl plastic which, in turn, is used in food contact applications and medical devices. The most widely-used phthalates are Di-2-Ethyl Hexyl Phthalate (DEHP), the Di-Isodecyl Phthalate (DIDP), and the Di-Isononyl Phthalate (DINP). Recent studies indicate that certain phthalate diesters and their metabolites are measurable in human breast milk, blood and other pregnancy-related specimens. In general, children's exposure to phthalates is greater than that of adults. Baby care products having phthalates are a source of exposure for infants [16]. A study showed that reported use of infant lotions, powders, and shampoos were associated with increased urine concentrations of phthalate metabolites, and this association is strongest in younger infants [17]. These findings suggest that dermal exposures may contribute significantly [18] to phthalate body burden in this population. Animal studies have documented an association between phthalate exposure and reproductive or developmental toxicity [19,20]. There have been a few human studies which suggest an indirect anti-androgenic action of phthalates in the perinatal period. Even, low-dose phthalate exposure may affect several markers of human male genital development [2,21,22]. In rats, phthalate exposure produced neurobehavioral, hepatic, immunologic and hepatotoxicity [23]. BPA and phthalates have shown substantial reproductive and developmental toxicity as evident from rodent studies. BPA and phthalates both function by formation of ROS and superoxide [24]. The oxidative stress produced as a result of the ROS formation, adversely affects the brain, testis, and kidney. BPA has been shown to cause oxidative damage in the brain of rats through ROS formation [25].

Thus, there are many toxicity data available in literature which are related with the long-term exposure of constituents of plastic containers [26-28]. However, there are no data on their influence on stability of therapeutic proteins. The instability and conformational changes in proteins may result in many pathological conditions many of which are chronic and life-debilitating [29].

Lysozyme is a129 amino acid residues enzyme which catalyzes hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan present in the bacterial cell walls [30]. This property has been used for determining its biological activity which would be reduced drastically due to the exposure of any unfavorable/destabilizing environments. Moreover, lysozyme is cheap, well investigated, and characterized protein. Its biochemical and biophysical characteristics are well reported in literature. Therefore, in this study we investigated the influence of exposure of BPA and DINPon the conformation stability and biological activity of lysozyme which would further corroborate the deleterious effect of plastic constituents by providing some additional new information at the conformation level of protein. A conformational change in biological protein can result in a complete loss of its activity or a gain of mutated/altered activity, resulting in the development of a disease in both conditions [31-33].

Materials and Methods


Bisphenol A (≥ 99%) and DINP technical grade (ester content ≥99 %) were purchased from SigmaAldrich, USA. Lysozyme (EC from chicken egg white and Micrococcus Lysodeikticus (Micrococcus luteus) was purchased from Sigma Chemical Company, St. Louis, MO. All other chemicals bought were of analytical reagent grade and used as obtained. Anhydrous dibasic sodium phosphate and citric acid needed to prepare Citrate-Phosphate (CP) buffer were purchased from Fisher Scientific, USA and used as received.


Preparation of citrate-phosphate buffer and lysozyme solution: Citrate Phosphate (CP) buffers of different pH were prepared by mixing the different proportions of 100mM citric acid and 200mM dibasic sodium phosphate stock solutions (Stoll and Blanchard, 1990). Lysozyme was dissolved at a concentration of 2 mg/mL (0.14mM) in the CP buffer (pH 4.4, 72.2mM) and centrifuged (4229 × g) for 20 minutes to remove any insoluble material. Supernatant was filtered through 0.1 μm Polytetrafluoroethylene (PTFE) filter (Millipore Corp., Bedford, MA) before using for exposure, thermodynamic and conformational evaluation studies. All pH measurements were done using a VWR Scientific model 8010 pH meter (VWR Scientific Products, Batavia,IL). Lysozyme was incubated to various concentrations (2-100 μM) of bisphenol A and DINP for7 days. Samples (3ml) were withdrawn at intervals of 1,3, and 7 days which were for studies using DSC and FTIR.

Thermodynamic evaluation of lysozyme sample: Conformational stability of lysozyme samples exposed to BPA/DINP was evaluated by using a Differential Scanning Calorimeter (DSC) (VP-DSC, MicroCal, Northampton, MA). All the lysozyme samples were centrifuged and supernatants were filtered through a 0.1 μm filter. These filtered supernatants and cp buffer were degassed by stirring using a magnetic bar under vacuum before loading into the DSC sample and reference cells, respectively. The heat flow needed to keep the sample cell and reference cell at the same temperature was recorded at a temperature range of 15°C to 95°C and a scan rate of1.5°C/min. At the beginning, the CP buffer was loaded in both sample cell and reference cells to ensure that the heat transition during protein conformational alterations is the only source of thermal difference between these two cells. This resulted in a baseline thermogram which was subtracted from the sample thermogram during data analysis. Midpoint transition temperature (Tm) and calorimetric enthalpy (ΔH) were used as conformational stability indicating thermodynamic parameters. A decrease in Δ H and Tm of the lysozyme was interpreted as an indicator of deleterious effect of BPA/DINP on conformational integrity of lysozyme. All data manipulations were performed by using Origin software (MicroCal) provided with the DSC.

Conformational characterization of lysozyme sample: The changes in the conformational integrity of the secondary structures of lysozyme solution exposed to BPA/DINP were further investigated by using Fourier Transform Infrared (FTIR) spectrophotometer. Forty microliters of the lysozyme samples exposed to BAP/DINP for 1, 3, and 7 days was placed in the sample compartment of the IR Prestige FTIR (Shimadzu, Kyoto, Japan). Spectra were obtained in the frequency range of 4000-1000 cm-1 in absorbance mode. The parameters selected for running thescans were resolution of 4 cm-1, average of 15 scans, and no apodization. Forty microliters of CP buffer was used to obtain the background spectra which was subtracted automatically from each sample spectrum. We used second derivative spectra for calculation of peaks in the region of 1600-1700 cm-1 wavenumber as indicators of various secondary structural components of lysozyme [34].

Determination of enzyme activity of lysozyme sample: Biological activity of the lysozyme samples exposed to BPA/DINP was figured out by an enzyme activity assay using Micrococcus lysodeikticus (M. luteus) as a substrate specific to ability of the native lysozyme to lyse cellular membrane [35]. Briefly, 100 mL sample of the bacteria M. luteus (0.0155 g) in CP buffer (pH 4.4) was prepared so that its absorbance at 450 nm was in the range of 1.0-2.0. Specific amounts of BPA/DINP exposed lysozyme samples were added to one Ml. M. luteus sample contained in a spectrophotometric cuvette and rate of decrease in absorbance was measured by operating the spectrophotometer (UV 1700, Shimanzu, Kyoto, Japan) in rate measurement mode using the parameters: wavelength = 450.0 nm, measure Time = 180 seconds with (δ) = 0.2, lag/rate = 5 seconds/175 seconds, and temperature = 25°C. The amount of lysozyme sample was optimized so that change in absorbance was about 0.2 unit. The blank CP buffer was used as the reference for the study. A rate of change of 0.001 in absorbance at 450 nm (A450 nm) was used to define 1 unit of biologically active lysozyme and was calculated by using following formula [36].

   Units of lysozyme/ml sample  = (ΔA450nm/ minTest - ΔA450nm/min Blank)(df)/(0.001)(0.1)

where, df = dilution factor

0.001 = Change in absorbance at A as per the unit definition,

0.1 = Volume (in ml) of sample/standard used.

Data analysis: Statistical comparisons were made using student’s t-test and Analysis of Variance (ANOVA). The level of significance was used as p<0.05.

Results and Discussion

In this study, CP buffer was used because it covers a sufficiently wide pH range and has a small enthalpy of ionization which minimizes heat effects due to protonation of [37] the protein. Figure 1 is the typical DSC thermogram of lysozyme which shows that folded state of lysozyme gets converted into the unfolded state at a specific temperature, Tm, due to absorption of heat indicated by H. Generally, a higher value of Tm and H indicate a greater conformational stability. Table 1 shows significant decrease in Tm and H values for lysozyme samples exposed to BPA or DINP with increase in exposure time indicating destabilization of conformational structure of lysozyme. This is important to note that the H value of BPA treated 7-day sample was negative which may indicate some drastic conformational change. In 7 days old DINP exposed samples, no measurable peak was observed which may be due to complete loss of conformational structure. DSC is ideally suited to the evaluation of the thermodynamic parameters of a protein during thermal denaturation since it measures the forces stabilizing the conformational structure directly as it is model independent [38]. The biophysical methods for the characterization of protein unfolding indicate that a loss in compact structure of protein resulting in non-native conformational change has a dramatic effect on aggregation [39], deamidation [40], and oxidation [41]. Biophysical studies have provided information about the relationship between protein unfolding and degree of stability [42] on the basis of Tm and ΔH values reported in a DSC thermogram [43].

Samples Tm (°K) Enthalpy (Cal/mole)
Lysozyme day 1 351.17 ± 273.50 9.5 ± 1.20E4
Lysozyme day 3 350.25 ± 273.30 9.4 ± 0.90E4
Lysozyme day 7 350.27 ± 274.20 9.3 ± 1.40E4
BPA day 1 349.92 ± 273.25 9.3 ± 1.40E4
BPA day 3 319.78 ± 273.25 1.6 ± 0.01E4
BPA day 7 310.68 ± 273.53 1.6 ± 0.09E4
DINP day 1 311.53 ± 273.28 1.9 ± 0.07E4
DINP day 3 283.95 ± 273.26 894.2 ± 11.2
DINP day 7 No Measurable Peak No Measurable Peak
Table 1: Thermodynamic parameters of lysozyme solutions in presence of BPA and DINP.

Figure 1A: A typical DSC thermogram of lysozyme.

These DSC data were further corroborated by FTIR spectroscopic investigation of lysozyme samples. This is one of the spectroscopic techniques which has been used regularly to evaluate the secondary structures of therapeutic proteins [44-46]. Figure 2A shows the FTIR spectra of 7 days old lysozyme sample and figure 2B of 1-day old lysozyme containing BPA where decrease in various peak intensity is evident. FTIR spectra of all the lysozyme samples exposed to BPA/DINP showed the splitting of β sheet secondary structure (Table 2). Furthermore, a complete loss of β sheet structure was found in the 7-day DINP exposed samples (Table 2) which also showed the minimal biological activity (Figure 3). M. Luteus is a specific substrate for lysozyme. It is able to break down bacterial cell membrane only if its native three-dimensional secondary structural conformation is intact. When M. luteus is lysed by lysozyme its absorbance decreases. Therefore, a rate ofdecrease of such absorbance is an estimation of lysozyme activity [37]. This approach has been used by other investigators too in various studies involving lysozyme [35,47-49]. It is clear from figure 3 that lysozyme samples exposed to BPA/DINP are containing significantly less (p<0.5) enzyme activity than the control samples not exposed to these chemicals at all-time points studied.

Samples Exposure Time
Lysozyme 1 1624
  3 1624
  7 1624
Lysozyme + BPA 1
Lysozyme + DINP 1
7 No peak
Table 2: Splitting of β sheet secondary structure.

Figure 2A: FTIR spectrum of lysozyme (7 day).


Figure 2B: FTIR spectrum of lysozyme containing BPA (1-day).


Figure 3: Enzyme activities of lysozyme exposed to BPA/DINP for 1, 3, and 7 days.

European Chemical Bureau’s 2003 Risk Assessment Report ( [50], indicates that exposure ofphthalate in infants with toys can be up to 250 μg/kg. Another study investigated the metabolites of phthalate in urine in the range of 132-44.3 μg/L [51]. Thus, the concentrations (0-100 μM) used in this study is in the lower range of possible amount of phthalate in humans. Therefore, the protein conformational disruption could be even greater due to real life burden of these chemicals.


We conclude that BPA and DINP (which are constituents of plastic bottles) disrupts the conformational stability of the model protein lysozyme which is expected to be more severe in real life because the greatest exposure period used in this study was only 7 days. Conformational changes in protein may cause many disease conditions such as Alzheimer and Parkinson, therefore, it would be better not to use plastic items containing BPA and DINP.


  1. Thompson RC, Swan SH, Moore CJ, vom Saal FS (2009) Our plastic age. Philos Trans R Soc Lond B Biol Sci 364: 1973-1976.
  2. Meeker JD, Sathyanarayana S, Swan SH (2009) Phthalates and other additives in plastics: human exposure and associated health outcomes. Philos Trans R Soc Lond B Biol Sci 364: 2097-2113.
  3. Wójcik-Fudalewska D, Normant-Saremba M, Anastácio P (2016) Occurrence of plastic debris in the stomach of the invasive crab Eriocheir sinensis. Mar Pollut Bull 113: 306-311.
  4. Heap B (2009) Was there a scientific consensus about risks associated with the rising accumulation, deposition and interaction of multiple forms of plastics and leached additives in the environment? Preface. Philos Trans R Soc Lond B Biol Sci 364: 1971.
  5. Liu ZH, Yin H, Dang Z (2017) Do estrogenic compounds in drinking water migrating from plastic pipe distribution system pose adverse effects to human? An analysis of scientific literature. Environ Sci Pollut Res Int 24: 2126-2134.
  6. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM (2009) Bisphenol- A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30: 75-95.
  7. Wagner M, Oehlmann J (2009) Endocrine disruptors in bottled mineral water: total estrogenic burden and migration from plastic bottles. Environ Sci Pollut Res Int 16: 278-286.
  8. Hankett JM, Collin WR, Yang P, Chen Z, Duhaime M (2016) Low-Volatility Model Demonstrates Humidity Affects Environmental Toxin Deposition on Plastics at a Molecular Level. Environ Sci Technol 50: 1304-1312.
  9. McKinney C, Rue T, Sathyanarayana S, Martin M, Seminario AL, et al. (2014) Dental sealants and restorations and urinary bisphenol A concentrations in children in the 2003-2004 National Health and Nutrition Examination Survey. J Am Dent Assoc 145: 745-750.
  10. McGovern V (2009) Polycarbonate plastics and human BPA exposure: urinary levels rise with use of drinking bottles. Environ Health Perspect 117: 406.
  11. Fernandez M, Bianchi M, Lux-Lantos V, Libertun C (2009) Neonatal exposure to bisphenol a alters reproductive parameters and gonadotropin releasing hormone signaling in female rats. Environ Health Perspect 117: 757-762.
  12. Newbold RR, Jefferson WN, Padilla-Banks E (2009) Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect 117: 879-885.
  13. Eckstrum KS, Edwards W, Banerjee A, Wang W, Flaws JA, et al. (2018) Effects of Exposure to the Endocrine-Disrupting Chemical Bisphenol A During Critical Windows of Murine Pituitary Development. Endocrinology 159:119-131.
  14. Yang M, Ryu JH, Jeon R, Kang D, Yoo KY(2009) Effects of bisphenol A on breast cancer and its risk factors. Arch Toxicol 83: 281-285.
  15. Rochester JR (2013) Bisphenol A and human health: a review of the literature. Reprod Toxicol 42: 132-155.
  16. Braun JM, Sathyanarayana S, Hauser R (2013) Phthalate exposure and children’s health. Curr OpinPediatr 25: 247-54.
  17. Sathyanarayana S, Karr CJ, Lozano P, Brown E, Calafat AM, et al. (2008) Baby care products: possible sources of infant phthalate exposure. Pediatrics 121: 260-268.
  18. Gong M, Weschler CJ, Liu L, Shen H, Huang L, et al. (2015) Phthalate metabolites in urine samples from Beijing children and correlations with phthalate levels in their handwipes. Indoor Air 25: 572-581.
  19. Kay VR, Chambers C, Foster WG (2013) Reproductive and developmental effects of phthalate diesters in females. Crit Rev Toxicol 43: 200-219.
  20. Kay VR, Bloom MS, Foster WG (2014) Reproductive and developmental effects of phthalate diesters in males. Crit Rev Toxicol 44: 467-498.
  21. Swan SH (2008) Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 108: 177-184.
  22. Spade DJ, Bai CY, Lambright C, Conley JM, Boekelheide K, et al. (2018) Validation of an automated counting procedure for phthalate-induced testicular multinucleated germ cells. Toxicol Lett 290: 55-61.
  23. Kovacic P (2010) How dangerous are phthalate plasticizers? Integrated approach to toxicity based on metabolism, electron transfer, reactive oxygen species and cell signaling. Med Hypotheses 74: 626-628.
  24. Sedha S, Kumar S, Shukla S (2015) Role of Oxidative Stress in Male Reproductive Dysfunctions with Reference to Phthalate Compounds. Urol J 12: 2304-2316.
  25. Kovacic P (2010) How safe is bisphenol A? Fundamentals of toxicity: metabolism, electron transfer and oxidative stress. Med Hypotheses 75: 1-4.
  26. Pozharny Y, Lambertini L, Clunie G, Ferrara L, Lee MJ (2010) Epigenetics in women’s health care. Mt Sinai J Med 77: 225-235.
  27. Berghuis SA, Bos AF, Sauer PJ, Roze E (2015) Developmental neurotoxicity of persistent organic pollutants: an update on childhood outcome. Arch Toxicol 89: 687-709.
  28. Bansal A, Henao-Mejia J, Simmons RA (2018) Immune System: An Emerging Player in Mediating Effects of Endocrine Disruptors on Metabolic Health. Endocrinology 159: 32-45.
  29. Denny RA, Gavrin LK, Saiah E (2013) Recent developments in targeting protein misfolding diseases. Bioorg Med Chem Lett 23: 1935-1944.
  30. Callewaert L, Michiels CW(2010) Lysozymes in the animal kingdom. J Biosci 35: 127-160.
  31. Gladkova C, Schubert AF, Wagstaff JL, Pruneda JN, Freund SM, et al. (2017) An invisible ubiquitin conformation is required for efficient phosphorylation by PINK1. EMBO J 36: 3555-3572.
  32. Broersen K, Ruiperez V, Davletov B (2018) Structural and Aggregation Properties of Alpha-Synuclei Linked to Phospholipase A2 Action. Protein Pept Lett 25: 368-378.
  33. Taguchi Y, Lu L, Marrero-Winkens C, Otaki H, Nishida N, et al. (2018) Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrPSc. J Biol Chem 293: 12730-12740.
  34. Blume K, Dietrich K, Lilienthal S, Ternes W, Drotleff AM (2015) Exploring the relationship between protein secondary structures, temperature-dependent viscosities, and technological treatments in egg yolk and LDL by FTIR and rheology. Food Chem173: 584-593.
  35. Chhabra S, Sachdeva V, Singh S (2007) Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system. Int J Pharm 342: 72-77.
  36. Shugar D (1952) The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme. Biochim Biophys Acta 8: 302-309.
  37. Stoll VS,Blanchard JS (1990) Buffers: Principles and Practice. In: Deutscher M, Abelson J (eds.). Guide to Protein Purification: Methods in Enzymology (Methods in Enzymology Series). Volume 182, Academic Press, London, UK. Pg: 24-37.
  38. Richard L, Remmele RL, Nancy SN, Subhashini S, Wayne RG (1998) Interleukin-1 Receptor (IL-1R) liquid formulation development using differential scanning calorimetry. Pharm Res 15: 200-208.
  39. Azuaga AI, Dobson CM, Mateo PL, Conejero LF (2002) Unfolding and aggregation during the thermal denaturation of streptokinase. Eur J Biochem 269: 4121-4133.
  40. Barone G, Catanzano F, Del Vecchio P, Giancola C, Graziano G (1997) Thermodynamics of protein stability: a family of ribonucleases. Pure Appl Chem 69: 2307-2313.
  41. Komsa PR, Koynova R, Kostov G, Tenchov B (2000) Discrete reduction of type 1 collagen thermal stability upon oxidation. Bio-phys Chem 83: 185-195.
  42. Sebastien B, Forbes RT, York P, Nyqvist H (1999) A central composite design to investigate the thermal stabilization of lysozyme. Pharm Res 16: 702-708.
  43. Chang BS, Randall CS, Lee YS (1993) Stabilization of lyophilized porcine pancreatic elastase. Pharm Res 10: 1478-1483.
  44. Bhattacharjee TT, Castilho ML, de Oliveira IR, Jesus VPS, Hewitt KC, et al. (2018) FTIR study of secondary structure changes in Epidermal Growth Factor by gold nanoparticle conjugation. Biochim Biophys Acta Gen Subj 1862: 495-500.
  45. Nadar SS, Rathod VK (2018) Encapsulation of lipase within Metal-Organic Framework (MOF) with enhanced activity intensified under ultrasound. Enzyme Microb Technol 108: 11-20.
  46. Lima CA, Goulart VP, Correa L, Zezell DM (2016) Using Fourier transform infrared spectroscopy to evaluate biological effects induced by photodynamic therapy. Lasers Surg Med 48(5):538-545.
  47. Singh S, Singh J (2003) Effect of polyols on the conformational stability and biological activity of a model protein lysozyme. AAPS PharmSciTech 4: 42.
  48. Carneiro IS, Menezes JNR, Maia JA, Miranda AM, Oliveira VBS, et al. (2018) Milk from transgenic goat expressing human lysozyme for recovery and treatment of gastrointestinal pathogens. Eur J Pharm Sci 112: 79-86.
  49. Steiert E, Radi L, Fach M, Wich PR (2018) Protein-Based Nanoparticles for the Delivery of Enzymes with Antibacterial Activity.Macromol Rapid Commun 39 (14): 1800186.
  51. Ait BY, Araki A, Kawai T, Tsuboi T, Saito I, et al. (2016) Exposure to phthalates in house dust and associated allergies in children aged 6-12years. Environ Int 96: 16-23.
Ocimum Scientific Publishers

This work is licensed under a Creative Commons Attribution 4.0 International License.  Creative Commons License

Copyright © 2019 - All Rights Reserved -